Although the function of LACTB in adipose has not been fully elucidated, these studies suggest that a reduction in LACTB function and, in turn, an increase in butanoate metabolism and decrease of succinylcarnitine levels are beneficial for obesity treatment. Here, LACTB is linked to obesity due to melanocortin 4 receptor deficiency.